Adaptimmune Therapeutics
ADAP
#9234
Rank
A$0.11 B
Marketcap
$0.43
Share price
4.45%
Change (1 day)
-75.54%
Change (1 year)

Adaptimmune Therapeutics (ADAP) - Net assets

Net assets on the balance sheet as of December 2024 : A$18.41 Million

According to Adaptimmune Therapeutics's latest financial reports the company has A$18.41 Million in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

Adaptimmune Therapeutics - Net assets on balance sheet (from 2014 to 2024)

Net assets by year

Year Net assets Change
2023-12-31$A$57.99 M-51.8%
2022-12-31$A$0.12 B-57.65%
2021-12-31$A$0.28 B-35.98%
2020-12-31$A$0.44 B151.3%
2019-12-31$A$0.17 B-49.61%
2018-12-31$A$0.35 B34.79%
2017-12-31$A$0.26 B12.8%
2016-12-31$A$0.23 B
2015-06-30$A$0.33 B13090.18%
2014-06-30$A$2.55 M-208.51%
2013-06-30$-A$2.36 Million1822.42%
2012-06-30$-A$0.13 Million

Net assets for similar companies or competitors

Company Net assets differencediff. Country
-A$0.97 Billion-5,364.93%๐Ÿ‡บ๐Ÿ‡ธ USA
A$72.45 M 293.42%๐Ÿ‡บ๐Ÿ‡ธ USA
-A$10.5 Million-156.98%๐Ÿ‡ณ๐Ÿ‡ฑ Netherlands
A$3.48 B 18,839.99%๐Ÿ‡บ๐Ÿ‡ธ USA